Results 141 to 150 of about 451,786 (281)

Implantable Cardioverter‐Defibrillators in Children: A 14‐Year Population‐Based Study

open access: yesJournal of Arrhythmia, Volume 42, Issue 2, April 2026.
Nationwide pediatric ICD cohort from Slovakia illustrating incidence, indications, shock outcomes, and device‐related adverse events, highlighting the predominance of secondary prevention and the clinical burden of inappropriate shocks and major complications.
Marko Bjeloševič   +4 more
wiley   +1 more source

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

open access: yesArthritis Care &Research, Volume 78, Issue 3, Page 417-423, March 2026.
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth   +19 more
wiley   +1 more source

Commissural Misalignment Following Valve‐in‐Valve Transcatheter Aortic Valve Implantation

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 1215-1224, March 1, 2026.
ABSTRACT Background Data on commissural misalignment (CMA) during valve‐in‐valve transcatheter aortic valve implantation (ViV‐TAVI) for valve failure after surgical aortic valve replacement (SAVR) is scarce. Aims To study the impact of CMA on clinical and hemodynamic outcomes following ViV‐TAVI for failed SAVR.
Matthias Raschpichler   +13 more
wiley   +1 more source

Wide QRS Tachycardia in WPW: When Antidromic AVRT Imitates VT

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Atrioventricular Re‐entry Tachycardia (AVRT) occurs in patients with accessory pathways (AP) via a re‐entry circuit between the AV node and the AP. Anterograde conduction through the AP causes antidromic AVRT with wide QRS complexes, which may mimic ventricular tachycardia (VT). We report a 59‐year‐old male with ischemic cardiomyopathy (EF 35%)
Aleksandra Grbović   +7 more
wiley   +1 more source

Atrial Fibrillation Among the NASA Astronaut Corps [PDF]

open access: yes
No abstract ...
Charvat, Jacqueline   +3 more
core   +1 more source

Novel Impedance‐Guided Contact Mapping Technique for the Circular Multielectrode Pulsed‐Field Ablation Catheter

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Impedance‐guided PulseSelect contact mapping (i‐Pulse) adapts EnSite X Contact Index for a circular multielectrode PFA catheter, enabling real‐time visualization of electrode–tissue contact without fluoroscopy. With ICE guidance, Δimpedance > 5% identified adequate contact, standardized tagging, and guided applications in three atrial ...
Kennosuke Yamashita   +5 more
wiley   +1 more source

Society for Maternal‐Fetal Medicine Consult Series #75: Evaluation and management of non‐immune hydrops fetalis

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Non‐immune hydrops fetalis (NIHF) can result from a multitude of underlying causes, such as fetal genetic diseases, congenital anomalies, infections, fetal arrhythmias, placental tumors, monochorionic twin complications, and other disorders.
Society for Maternal‐Fetal Medicine (SMFM)   +3 more
wiley   +1 more source

The Fibrillatory Wave Amplitude of ECG Decreases Over Time in Patients With Persistent AF: A Retrospective Cohort Study

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 2, March 2026.
The fibrillatory wave amplitude of ECG decreases over time in patients with persistent AF: A Retrospective Cohort Study. ABSTRACT Background A prolonged history of atrial fibrillation (AF) is associated with increased recurrence rates, and ablation is not recommended for AF lasting over 10 years. In some developing countries, patients may be unaware of
Jing Li   +3 more
wiley   +1 more source

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib and Effect on the QT/QTc Interval in Healthy Participants

open access: yesClinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Fenebrutinib is a Bruton's tyrosine kinase inhibitor under investigation for the treatment of multiple sclerosis. The goal of this study was to investigate the effect of fenebrutinib on cardiac repolarization (QT interval) as well as its safety, tolerability, and pharmacokinetics in healthy participants.
Yan Xu   +7 more
wiley   +1 more source

Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2183-2202, March 2026.
Abstract Aims The extent to which the cardiovascular benefits of sodium–glucose co‐transporter 2 inhibitors (SGLT‐2is) and glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) differ by sex remains unclear. This systematic meta‐analysis aimed to investigate sex differences in trial representation and the cardiovascular and kidney efficacy of SGLT‐2is ...
Magdaline Zawadka   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy